Pd Rx Pharmaceutical Stock Net Income
| PDRX Stock | USD 2.90 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Pd-Rx Pharmaceutical's long-term financial health and intrinsic value.
Pd-Rx |
Pd Rx Pharmaceutical Company Net Income Analysis
Pd-Rx Pharmaceutical's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Pd-Rx Pharmaceutical Net Income | 1.86 M |
Most of Pd-Rx Pharmaceutical's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pd Rx Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Pd Rx Pharmaceutical reported net income of 1.86 M. This is 99.46% lower than that of the Health Care Providers & Services sector and 99.09% lower than that of the Health Care industry. The net income for all United States stocks is 99.67% higher than that of the company.
Pd-Rx Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pd-Rx Pharmaceutical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Pd-Rx Pharmaceutical could also be used in its relative valuation, which is a method of valuing Pd-Rx Pharmaceutical by comparing valuation metrics of similar companies.Pd Rx is currently under evaluation in net income category among its peers.
Pd-Rx Fundamentals
| Return On Equity | 0.25 | |||
| Return On Asset | 0.0556 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 4.45 M | |||
| Shares Outstanding | 1.72 M | |||
| Price To Earning | 3.33 X | |||
| Price To Sales | 0.40 X | |||
| Revenue | 21.6 M | |||
| Gross Profit | 6.96 M | |||
| EBITDA | 991.1 K | |||
| Net Income | 1.86 M | |||
| Cash And Equivalents | 104.55 K | |||
| Cash Per Share | 0.06 X | |||
| Total Debt | 466.84 K | |||
| Debt To Equity | 0.31 % | |||
| Current Ratio | 4.14 X | |||
| Book Value Per Share | 4.95 X | |||
| Cash Flow From Operations | (465.77 K) | |||
| Earnings Per Share | 1.08 X | |||
| Beta | -0.16 | |||
| Market Capitalization | 10.29 M | |||
| Z Score | 13.2 | |||
| Annual Yield | 0.11 % |
About Pd-Rx Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pd Rx Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pd-Rx Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pd Rx Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Pd-Rx Pink Sheet Analysis
When running Pd-Rx Pharmaceutical's price analysis, check to measure Pd-Rx Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pd-Rx Pharmaceutical is operating at the current time. Most of Pd-Rx Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Pd-Rx Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pd-Rx Pharmaceutical's price. Additionally, you may evaluate how the addition of Pd-Rx Pharmaceutical to your portfolios can decrease your overall portfolio volatility.